Eton Pharmaceuticals (ETON) Change in Receivables (2020 - 2025)

Eton Pharmaceuticals (ETON) has 6 years of Change in Receivables data on file, last reported at -$1.3 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Receivables fell 241.11% year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2025 stood at $6.4 million (up 105.13% YoY), and the FY2025 full-year result was $6.4 million, up 105.13% from the prior year.
• Change in Receivables rose to -$1.3 million in Q4 2025, from -$1.4 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $11.0 million in Q1 2025 to a low of -$4.7 million in Q1 2022.
• A 5-year average of $643850.0 and a median of $303000.0 in 2021 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables jumped 10495.83% in 2021 and plunged 1955.16% in 2022, its largest moves.
• Tracing ETON's Change in Receivables over 5 years: stood at $5.1 million in 2021, then sank by 93.04% to $354000.0 in 2022, then plunged by 123.73% to -$84000.0 in 2023, then surged by 1217.86% to $939000.0 in 2024, then tumbled by 241.11% to -$1.3 million in 2025.
• Business Quant data shows ETON's Change in Receivables at -$1.3 million in Q4 2025, -$1.4 million in Q3 2025, and -$1.9 million in Q2 2025.